| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 02/18/1997 | US5603959 Non-steroidal anti-inflammatory drug linked with unsaturated fatty acid or alcohol; cytoprotective agents, side effect reduction |
| 02/17/1997 | CA2183307A1 Endothelin receptor antagonists |
| 02/15/1997 | CA2183048A1 Substituted 4h-pyrans |
| 02/13/1997 | WO1997004784A1 Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
| 02/13/1997 | WO1997004763A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/13/1997 | WO1997004753A1 Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 02/13/1997 | WO1997004752A1 Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 02/13/1997 | DE19529612A1 Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate Sulfonyl or sulfinyl derivatives benzoylguanidine |
| 02/13/1997 | CA2228178A1 Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods |
| 02/12/1997 | EP0757982A1 Biphenylic compounds, process for their preparations and intermediates for this process, their use as 5-alpha-reductase inhibitors and pharmaceutical compositions containing them |
| 02/12/1997 | EP0757718A1 Methods of use of uncoated gel particles |
| 02/12/1997 | EP0757670A1 Benzamide derivatives as vasopressin antagonists |
| 02/12/1997 | EP0757669A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142826A Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142817A 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
| 02/12/1997 | CN1142816A Crystalline, polymorphic form of (S,S,S)-n-(1-|2-carboxy-3-(n2-mesyllysylamino)propyl¨-1-cyclopenlylcarbonyl)tyrosine |
| 02/12/1997 | CA2183012A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 02/11/1997 | US5602169 Useful in reducing neuronal damage during ischemic stroke |
| 02/11/1997 | US5602137 Treating cardiovascular or circulatory disorders |
| 02/11/1997 | US5602136 Cardiovascular and nervous system disorders |
| 02/11/1997 | US5602133 Treatment of polycystic ovary syndrome |
| 02/11/1997 | US5602132 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 02/11/1997 | US5602116 Administering vitamin d analog |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601804 Antiplaque agent |
| 02/11/1997 | CA2054212C Method for polymerization of epoxide compounds |
| 02/11/1997 | CA1338906C 11 beta-substituted progesterone analogs |
| 02/06/1997 | WO1997003985A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003699A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1997003675A1 Use of cgmp-phosphodiesterase inhibitors to treat impotence |
| 02/06/1997 | WO1997003668A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 02/06/1997 | WO1997003653A1 Enterogenin pharmaceutical form |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | CA2226761A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 02/06/1997 | CA2200295A1 Enterogenin pharmaceutical form |
| 02/05/1997 | EP0757039A1 Endothelin receptor antagonists |
| 02/05/1997 | EP0756482A1 Transdermal delivery of alpha adrenoceptor blocking agents |
| 02/05/1997 | CN1142185A Composition for contraception |
| 02/05/1997 | CN1033976C Preparation of polypeptides used as blockers of calcium channels |
| 02/05/1997 | CN1033975C Preparation of 2beta, 19-ethylene bridged steroids as aromatase inhibitors |
| 02/04/1997 | US5599830 Sulphorous derivatives of imidazole and their use as medicaments |
| 02/04/1997 | US5599822 Methods for minimizing bone loss |
| 02/04/1997 | US5599811 Phenyl or dioxyphenyl substituents; drugs |
| 02/04/1997 | US5599810 Furo- and thieno[4,3,2-ef][3]benzazepines useful as alpha adrenergic receptor antagonists |
| 02/04/1997 | US5599796 Treatment of urogenital cancer with boron neutron capture therapy |
| 02/04/1997 | US5599559 Calcium channel blocking polypeptide from agelenopsis aperta and therapeutic methods employing it |
| 02/03/1997 | CA2182469A1 Endothelin-receptor-antagonists |
| 01/30/1997 | WO1997003071A1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
| 01/30/1997 | WO1997003067A1 Piperazine derivatives as therapeutic agents |
| 01/30/1997 | WO1997003066A1 Substituted benzolactam compounds as substance p antagonists |
| 01/30/1997 | WO1997002835A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | WO1997002832A1 Lyophilized hgf preparations |
| 01/30/1997 | WO1997002826A2 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 01/30/1997 | CA2226392A1 Intranasal vaccination against gastrointestinal disease |
| 01/30/1997 | CA2223472A1 Therapeutic agents |
| 01/29/1997 | EP0755934A1 Endothelin receptor antagonists |
| 01/29/1997 | EP0755931A1 Dihydropyridine and pyridine derivatives and process for their preparation |
| 01/29/1997 | EP0755919A2 Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them |
| 01/29/1997 | EP0755443A1 Tissue-specific enhancer active in prostate |
| 01/29/1997 | EP0755392A1 Alpha1c adrenergic receptor antagonists |
| 01/29/1997 | EP0755382A1 Quinolone derivative for treatment of urinary incontinence |
| 01/29/1997 | EP0723453A4 Method of treating reproductive disorders |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141625A Vitamin D amine and amine derivatives |
| 01/29/1997 | CN1141590A Agent for prophylaxis and treatment of thromboxane A2-mediated diseases |
| 01/29/1997 | CN1141298A Pyrimidine-fused heterocyclic compound anti-cancer agents |
| 01/29/1997 | CN1141297A Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders |
| 01/29/1997 | CA2182156A1 Endothelin-receptor-antagonists |
| 01/28/1997 | US5597826 Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
| 01/28/1997 | US5597815 Prevention of hyperphosphatemia in kidney disorder patients |
| 01/28/1997 | CA2039194C Uses of l-deprenyl and compositions for same |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002032A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
| 01/23/1997 | WO1997000063A3 Urocortin peptides |
| 01/23/1997 | CA2224451A1 Method of treating renal disease using an ace inhibitor and an aii antagonist |
| 01/22/1997 | EP0754687A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/22/1997 | EP0754456A2 Topical application of ST1435 as a contraceptive agent |
| 01/22/1997 | EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
| 01/22/1997 | EP0754189A1 Receptor modulating agents and methods relating thereto |
| 01/22/1997 | EP0754054A1 Antirestenosis protein |
| 01/22/1997 | EP0754043A1 Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 01/22/1997 | EP0754041A1 Novel substituted tryptamines, phenalkylamines and related compounds |
| 01/22/1997 | EP0754040A1 Rapamycin derivatives |
| 01/22/1997 | EP0461200B1 Modified forms of reproductive hormones |
| 01/22/1997 | CN1141033A DP-IV-serine protease inhibitors |
| 01/22/1997 | CN1140993A Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding |
| 01/22/1997 | CN1140990A Transdermal presentation of nitroglycerin for preventing undesived labour |
| 01/21/1997 | US5596004 Methods of inhibiting male infertility |
| 01/21/1997 | US5595995 Anticarcinogenic agents |
| 01/21/1997 | US5595970 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors |
| 01/21/1997 | CA2028235C Condensed purine derivatives |
| 01/21/1997 | CA2022682C Cycloalkylene azoles, processes for their production and use, and pharmaceutical preparations obtained therefrom |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0752883A1 Use of mcp-1 for inducing ripening of the cervix |
| 01/15/1997 | EP0752879A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES |
| 01/15/1997 | EP0752871A1 Adhesion inhibiting composition |